Research from Water Tower Research, Water Tower Research

Water Tower Research

Water Tower Research is a leading equity research firm that provides research on micro, small and mid cap companies.

Water Tower Research was founded by Wall Street veterans after witnessing a fundamental shift in the investment research industry with the result being a declining knowledge base among investors, a lack of awareness and a shrinking pool of fundamental research being conducted on companies across the small-cap and micro-cap spectrum. The same issues are now increasingly occurring in the mid-cap space. This sea change within the investment community is impacting not only the companies themselves but also current shareholders and potential investors. With significantly less active sell-side sponsorship by Wall Street, a substantial information gap has developed between companies and various constituents in the financial community. The net result is fewer channels for insight and information to flow between companies and investors.

Research from Water Tower Research

Equity Research Firm

Equity Bottom-Up

<ul><li>Differentiated, minimally invasive technology platform. </li><li>NurExone’s lead product candidate, ExoPTEN, uses exosomes loaded with siRNA to promote neural regeneration after central nervous system trauma such acute spinal cord injury or optic nerve injury.</li><li>Unlike competing approaches (e.g., stem cell transplants or electrical stimulation), ExoPTEN is cell-free, crosses the blood-brain barrier naturally, and can be administered with minimal invasiveness, all of which bring a significant clinical and operational advantage.</li></ul>

Differentiated, minimally invasive technology platform. NurExone’s lead product candidate, ExoPTEN, uses exosomes loaded with siRNA to promote neural regeneration after central nervous system trauma such acute spinal cord injury or optic nerve injury.Unlike competing approaches (e.g., stem cell transplants or electrical stimulation), ExoPTEN is cell-free, crosses the blood-brain barrier naturally, and can be administered with minimal invasiveness, all of which bring a significant clinical and operational advantage.

NRX：前臨床段階での有望性から臨床応用へ

Nurexone Biologic

NRX：前臨床段階での有望性から臨床応用へ